NEW YORK STATE COMMON RETIREMENT FUND
PensionPosition in CRVS — Corvus Pharmaceuticals, Inc.
CIK 810265
ALBANY, NY
Position in CRVS
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$374,994
+$110,191 QoQ
Shares Held
25,100
+38.7% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#107
of 172 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NEW YORK STATE COMMON RETIREMENT FUND holds $953,600,073 across 287 Biotechnology names. CRVS ranks #128 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
277,614 | $137,899,202 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
111,369 | $69,443,026 | |
| 3 | ASND |
Ascendis Pharma A/S
|
191,791 | $51,154,495 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
94,743 | $50,872,253 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
137,258 | $43,385,881 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
500,050 | $39,648,964 | |
| 7 | INSM |
INSMED Inc
|
304,236 | $32,437,642 | |
| 8 | MIRM |
Mirum Pharmaceuticals, Inc.
|
250,558 | $29,332,825 |
All Filings in CRVS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $374,994 | 25,100 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $264,803 | 18,100 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $144,760 | 18,800 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $138,556 | 18,800 | Shares | Sole | 2025-11-03 | |
| No filing history on record for this holder in this stock. | ||||||